However, it has been shown that CDK4 and CDK6 can differentially regulate cancer progression through various mechanisms in breast, prostate, and pancreatic cancer models, with the CDK4-dependent regulation of pro-metastatic inflammatory pathways, and the CDK6-dependent control of the genes that are involved in DNA replication and repair mechanisms. This evidence concerns the gene CDK6 and cancer.